Population Pharmacokinetics of Conventional and Intermittent Dosing of Liposomal Amphotericin B in Adults: A First Critical Step for Rational Design of Innovative Regimens

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00933-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacokinetics of Liposomal Amphotericin B (Ambisome) in Critically Ill Patients.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Toxicological Profile and Pharmacokinetics of a Unilamellar Liposomal Vesicle Formulation of Amphotericin B in Rats

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Liposomal Amphotericin B

Medical mycology journal
Infectious DiseasesMicrobiology
2005English

Population Pharmacokinetics and Dosing Regimen Design of Milrinone in Preterm Infants

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
2007English

Amphotericin B Pharmacokinetics in Humans

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1978English

Population Pharmacokinetics of Gentamicin and Dosing Optimization for Infants

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Budget Impact Analysis of Liposomal Amphotericin B and Amphotericin B Lipid Complex for Treating Invasive Fungal Infections in Hospitalized Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Pharmacokinetics of Amphotericin B Colloidal Dispersion in Liver Failure

BMC Pharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy